Dana-Farber at South Shore Hospital

Weymouth, Massachusetts 02190

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Invasive Carcinoma of the Breast, Micrometastasis Breast Cancer, Node Negative Breast Cancer, Other Cancer, Stage II Breast Cancer, Stage III Breast Cancer

Studies at this site

• ATEMPT 2.0: Adjuvant T-DM1 vs TH — Recruiting now
• A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer — Running, not enrolling
• MARGetuximab Or Trastuzumab (MARGOT) — Running, not enrolling
• Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation — Completed
• Cisplatin + RT for Triple Negative Breast Cancer — Completed